Clinical Trial Update: A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is comparing multiple doses of NNC0662-0419 for blood sugar lowering in adults with type 2 diabetes; the study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0662-0419

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: NOT_YET_RECRUITING